IDH1 gene mutation activates Smad signaling molecules to regulate the expression levels of cell cycle and biological rhythm genes in human glioma U87‑MG cells-Reference-Cited by-同舟云学术

IDH1 gene mutation activates Smad signaling molecules to regulate the expression levels of cell cycle and biological rhythm genes in human glioma U87‑MG cells

Published:2021-03-12 Issue:5 Volume:23 Page:
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:
Short-container-title:Mol Med Rep

Author:

Gao Yongying¹,Wu Yanwei¹,Zhang Ningmei²,Yuan Hongmei³,Wang Fei⁴,Xu Hui¹,Yu Jiaxiang¹,Ma Jie¹,Hou Shaozhang¹,Cao Xiangmei¹

Affiliation:

1. Department of Pathology, School of Basic Medicine, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China

2. Department of Pathology, Tumor Hospital, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China

3. Functional Department, Ningxia Hui Autonomous Region People's Hospital, Yinchuan, Ningxia 750021, P.R. China

4. Department of Pathology, The First People's Hospital of Yinchuan, Yinchuan, Ningxia 750001, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the therapeutic potential of Potentilla fragarioides var. major (Rosaceae) extract in Alzheimer’s disease using in vitro and in vivo models: A multi-faceted approach;Neuroscience;2024-11

2. Biological clock regulation by the PER gene family: a new perspective on tumor development;Frontiers in Cell and Developmental Biology;2024-05-15

3. Molecular mechanisms of tumour development in glioblastoma: an emerging role for the circadian clock;npj Precision Oncology;2024-02-20

4. Review: therapeutic approaches for circadian modulation of the glioma microenvironment;Frontiers in Oncology;2023-12-20

5. Overview on Common Genes Involved in the Onset of Glioma and on the Role of Migraine as Risk Factor: Predictive Biomarkers or Therapeutic Targets?;Journal of Personalized Medicine;2022-11-28